Literature DB >> 21235132

Cold atmospheric plasma jet effects on V79-4 cells.

Andreea-Roxana Lupu1, N Georgescu.   

Abstract

The effects of cold plasmas are due to charged particles, reactive oxygen species (ROS), reactive nitrogen species (RNS), UV photons, and intense electric field. In order to obtain a more efficient action on mammalian cells (useful for cancer therapy), we used in our studies chemically activated cold plasma (He and O2 gas mixture). V79-4 cells were exposed to plasma jet for different time periods (30, 60, 90, 120 and 150s), using different combinations of helium and oxygen inputs (He:2.5l/min + 02:12.5ml/min; He:2.51/min + O2:25ml/min; He:2.51/min + O2:37.5 ml/min). Using MTT test we demonstrated that plasma jet induced cell viability decrease in all cases. The effect of chemically activated cold plasma--apoptosis or necrosis--depends on gas mixture and treatment period. Taking into account that ROS density in cell microenvironment is related to O2 percent in the gas mixture and treatment period, we can presume that cell death is due to ROS produced in plasma jet.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21235132

Source DB:  PubMed          Journal:  Roum Arch Microbiol Immunol        ISSN: 1222-3891


  8 in total

1.  Combination of cold atmospheric plasma and iron nanoparticles in breast cancer: gene expression and apoptosis study.

Authors:  Azam Jalili; Shiva Irani; Reza Mirfakhraie
Journal:  Onco Targets Ther       Date:  2016-09-28       Impact factor: 4.147

2.  Cold atmospheric helium plasma causes synergistic enhancement in cell death with hyperthermia and an additive enhancement with radiation.

Authors:  Rohan Moniruzzaman; Mati Ur Rehman; Qing-Li Zhao; Paras Jawaid; Keigo Takeda; Kenji Ishikawa; Masaru Hori; Kei Tomihara; Kyo Noguchi; Takashi Kondo; Makoto Noguchi
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

3.  Cold Atmospheric Plasma, a Novel Approach against Bladder Cancer, with Higher Sensitivity for the High-Grade Cell Line.

Authors:  Edgar Tavares-da-Silva; Eurico Pereira; Ana S Pires; Ana R Neves; Catarina Braz-Guilherme; Inês A Marques; Ana M Abrantes; Ana C Gonçalves; Francisco Caramelo; Rafael Silva-Teixeira; Fernando Mendes; Arnaldo Figueiredo; Maria Filomena Botelho
Journal:  Biology (Basel)       Date:  2021-01-09

4.  Cold atmospheric plasma (CAP) changes gene expression of key molecules of the wound healing machinery and improves wound healing in vitro and in vivo.

Authors:  Stephanie Arndt; Petra Unger; Eva Wacker; Tetsuji Shimizu; Julia Heinlin; Yang-Fang Li; Hubertus M Thomas; Gregor E Morfill; Julia L Zimmermann; Anja-Katrin Bosserhoff; Sigrid Karrer
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

5.  Cold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells.

Authors:  Rafael Guerrero-Preston; Takenori Ogawa; Mamoru Uemura; Gary Shumulinsky; Blanca L Valle; Francesca Pirini; Rajani Ravi; David Sidransky; Michael Keidar; Barry Trink
Journal:  Int J Mol Med       Date:  2014-07-11       Impact factor: 4.101

6.  Cold Atmospheric Plasma: A Promising Complementary Therapy for Squamous Head and Neck Cancer.

Authors:  Christian Welz; Steffen Emmert; Martin Canis; Sven Becker; Philipp Baumeister; Tetsuji Shimizu; Gregor E Morfill; Uli Harréus; Julia L Zimmermann
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

7.  Helium-based cold atmospheric plasma-induced reactive oxygen species-mediated apoptotic pathway attenuated by platinum nanoparticles.

Authors:  Paras Jawaid; Mati Ur Rehman; Qing Li Zhao; Keigo Takeda; Kenji Ishikawa; Masaru Hori; Tadamichi Shimizu; Takashi Kondo
Journal:  J Cell Mol Med       Date:  2016-06-02       Impact factor: 5.310

Review 8.  Molecular Mechanisms of the Efficacy of Cold Atmospheric Pressure Plasma (CAP) in Cancer Treatment.

Authors:  Marie Luise Semmler; Sander Bekeschus; Mirijam Schäfer; Thoralf Bernhardt; Tobias Fischer; Katharina Witzke; Christian Seebauer; Henrike Rebl; Eberhard Grambow; Brigitte Vollmar; J Barbara Nebe; Hans-Robert Metelmann; Thomas von Woedtke; Steffen Emmert; Lars Boeckmann
Journal:  Cancers (Basel)       Date:  2020-01-22       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.